#ASCO14 - Poster: Patient-reported quality of life analysis of radium-223 dichloride evaluating pain relief from the phase 3 ALSYMPCA study

CHICAGO, IL USA (UroToday.com) - Presented by Sten Nilsson,1 Michael Tomblyn,2 Paul Cislo,3 Jonathan Reuning-Scherer,4 and Christopher Parker5 at the American Society of Clinical Oncology (ASCO) 50th Annual Meeting - May 30 - June 3, 2014 - Chicago, Illinois USA

asc0 2014 nilsson poster thumb

1Karolinska University Hospital, Stockholm, Sweden
2Algeta US (Bayer), Cambridge, MA, USA
3Bayer HealthCare, Whippany, NJ, USA
4Yale University, New Haven, CT, USA
5The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, UK